Birdwatch Archive

Birdwatch Note Rating

2022-08-09 02:29:28 UTC - HELPFUL

Rated by Participant: E2DBA5C738DBA285405B039D0EC7E3901ADCFCBF2A6665AC91C536CBFF260613
Participant Details

Original Note:

The FDA has already announced that it will not require BA.4/5 vaccine trials to be completed before authorizing redesigned boosters for those variants, and is willing to authorize BA.4/5 boosters based on trials for other vaccine variants, so the September date is realistic. https://www.reuters.com/business/healthcare-pharmaceuticals/fda-will-not-require-clinical-trial-data-authorize-redesigned-covid-boosters-2022-06-30/

All Note Details

Original Tweet

All Information

  • noteId - 1556693675563892736
  • participantId -
  • raterParticipantId - E2DBA5C738DBA285405B039D0EC7E3901ADCFCBF2A6665AC91C536CBFF260613
  • createdAtMillis - 1660012168404
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1556693675563892736E2DBA5C738DBA285405B039D0EC7E3901ADCFCBF2A6665AC91C536CBFF260613